Top

Published in:

01-07-2018

More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin

Authors: Jeffrey Y. Bien, MD, Derrick L. Tao, Molly M. Daughety, Thomas G. DeLoughery, Joseph J. Shatzel

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2018

Excerpt

Whether aspirin carries a favorable safety profile compared to direct oral anticoagulants (DOACs) remains a topic of controversy. A recent study by Hsu et al. illustrates how providers often preferentially choose aspirin for patients they perceive to be at high risk of bleeding, noting that over 38% of patients who qualify for additional anticoagulation per guidelines are actually managed on aspirin alone in real life practice [1]. …

Hsu JC, Maddox TM, Kennedy K et al (2016) Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke. J Am Coll Cardiol 67:2913–2923. https://doi.org/10.1016/j.jacc.2016.03.581 CrossRefPubMed

Mant J, Hobbs FR, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370:493–503. https://doi.org/10.1016/S0140-6736(07)61233-1 CrossRefPubMed

Chai-Adisaksopha C, Crowther M, Isayama T, Lim W (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124:2450–2458. https://doi.org/10.1182/blood-2014-07-590323 CrossRefPubMed

Weitz JI, Lensing AWA, Prins MH et al (2017) Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 376:1211–1222. https://doi.org/10.1056/NEJMoa1700518 CrossRefPubMed

Connolly SJ, Eikelboom J, Joyner C et al (2011) Apixaban in patients with atrial fibrillation. N Engl J Med 364:806–817. https://doi.org/10.1056/NEJMoa1007432 CrossRefPubMed

January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:2071–2104. https://doi.org/10.1161/CIR.0000000000000040 CrossRefPubMed

Kearon C, Akl EA, Ornelas J et al (2016) Antithrombotic therapy for VTE disease: chest guideline and expert panel report. Chest 149:315–352. https://doi.org/10.1016/j.chest.2015.11.026 CrossRefPubMed

Title: More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin
Authors: Jeffrey Y. Bien, MD
Derrick L. Tao
Molly M. Daughety
Thomas G. DeLoughery
Joseph J. Shatzel
Publication date: 01-07-2018
Publisher: Springer US
Published in: Journal of Thrombosis and Thrombolysis / Issue 1/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-018-1648-8

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2018

What is the importance of real-time three dimensional transesophageal echocardiography and time in therapeutic range in patients with prosthetic valve thrombosis?

Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population

Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients

Cerebral venous sinus thrombosis complicated by seizures

Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium

Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page